Inguavuma virus

Ingvavuma virus belongs to the genus Bunyavirus of the family Bunyavirus and the ecological group of Arbovirus. It has the Simbu antigenic group and its pathogenicity for humans has not yet been established.

Ingwavuma virus was first discovered in 1963 in Uganda. It causes a disease that can occur in different forms: from mild to severe. Symptoms may include fever, headache, muscle pain, nausea, vomiting and diarrhea.

Diagnosing Inguavuma virus can be difficult because it has no specific diagnostic tests. Diagnosis is usually made based on clinical manifestations and epidemiological data.

There is no treatment for Inguavuma virus, but patients can receive symptomatic treatment. It is also recommended that patients be isolated for 21 days after exposure to the virus to prevent the spread of infection.

Prevention of Inguavuma virus includes vaccination against other arbovirus infections that may be associated with this virus. It is also important to take precautions when visiting areas where the virus is found, such as wearing protective clothing, using repellents, and avoiding contact with water and insects.

Currently, there are many infectious diseases known in the world, and one of them is the Ingvavumu virus. This infectious microorganism is an arboviral disease, which was previously called yellow fever. The name Virus "Ebo" or VHEV (Virus hemorrhagic fever ebola) means severe hemorrhagic fever syndrome,